Variable | N (%) | Non-adherence/total (%) | PR [CI 95%] | p value |
---|---|---|---|---|
Age** | 30 [24–38.50] | 29 [24–39] |  | 0.646 |
Sex | ||||
 Male | 144 (80.0) | 81/144 (56.3) |  |  |
 Female | 36 (20.0) | 24/36 (66.7) | 0.84 [0.64–1.11] | 0.257 |
Sexual orientation | ||||
 Homosexual | 63 (35.0) | 35/63 (55.6) |  | 0.853 |
 Heterosexual | 89 (49.4) | 53/89 (59.6) | 1.07 [0.81–1.42] |  |
 Bisexual | 28 (15.6) | 17/28 (60.7) | 1.09 [0.75–1.58] |  |
Marital status | ||||
 Single | 122 (67.8) | 68/122 (55.7) |  | 0.778 |
 Living with someone/partner | 35 (19.4) | 22/35 (62.9) | 1.13 [0.84–1.52] |  |
 Married | 12 (6.7) | 8/12 (66.7) | 1.20 [0.78–1.84] |  |
 Divorced/widowed | 11 (6.1) | 7/11 (63.6) | 1.14 [0.71–1.83] |  |
Number of children | ||||
 0 | 115 (63.9) | 60/115 (52.2) |  | 0.029* |
 1 | 21 (11.7) | 13/21 (61.9) | 1.19 [0.81–1.73] |  |
 2 | 25 (13.9) | 19/25 (76) | 1.46 [1.10–1.93] |  |
 ≥ 3 | 19 (10.6) | 13/19 (68.4) | 1.31 [0.92–1.86] |  |
Monthly family incomes** | 1000 [625–1500] | 1000 [700–1800] |  | 0.302 |
ART prescription | ||||
 ZDV + 3TC + EFV | 62 (34.4) | 39/62 (62.9) |  | 0.861 |
 TDF + 3TC + EFV | 47 (26.1) | 25/47 (53.2) | 0.85 [0.61–1.18] |  |
 ABC + 3TC + EFV | 26 (14.4) | 14/26 (53.8) | 0.86 [0.57–1.28] |  |
 TDF + 3TC + ATV + RTV | 15 (8.3) | 9/15 (60) | 0.95 [0.61–1.50] |  |
 Other | 30 (16.7) | 18/30 (60) | 0.95 [0.67–1.35] |  |
Place of diagnosis | ||||
 Hospital | 95 (52.8) | 60/95 (63.2) |  | 0.035* |
 Primary Health Center | 59 (32.8) | 32/59 (54.2) | 0.86 [0.65–1.14] |  |
 Private lab or clinic | 16 (8.9) | 5/16 (31.3) | 0.49 [0.24–1.04] |  |
 Ambulatory care | 10 (5.6) | 8/10 (80) | 1.27 [0.90–1.79] |  |
Viral Load | Â | Â | Â | 0.513 |
  > 40 | 81 (45.0) | 51/81 (63) |  | 0.255 |
  ≤ 40 | 99 (55.0) | 54/99 (54.5) | 1.15 [0.90–1.48] |  |
Nivel de CD4** | 356 [261–527] | 362 [264–516] |  | 0.879 |
 ≤ 300 | 66 (36.7) | 37/66 (56.1) |  | 0.638 |
 > 300 | 114 (63.3) | 68/114 (59.6) | 0.94 [0.72–1.22] |  |
Years with no ART since diagnosis** | 2 [1–5] | 2 [1–5] |  | 0.662 |
 ≥ 1 | 45 (25) | 26/45 (57.8) |  | 0.930 |
 < 1 | 135 (75) | 79/135 (58.5) | 0.99 [0.74–1.32] |  |
Years living with HIV** | 2 [1–3] | 2 [1–3] |  | 0.980 |
 ≥ 1 | 141 (78.3) | 86/141 (61) |  | 0.169 |
 < 1 | 39 (21.7) | 19/39 (48.7) | 1.25 [0.88–1.77] |  |
Years taking ART** | 1 [1, 2] | 1 [1, 2] | Â | 0.988 |
 ≥ 1 | 122 (67.8) | 73/122 (59.8) |  | 0.553 |
 < 1 | 58 (32.2) | 32/58 (55.2) | 1.08 [0.82–1.43] |  |
Opportunistic infection | ||||
 Yes | 80 (44.4) | 43/80 (53.8) |  | 0.265 |
 No | 100 (55.6) | 62/100 (62) | 0.87 [0.67–1.12] | |
Pulmonary tuberculosis | ||||
 Yes | 18 (10.0) | 6/18 (33.3) |  | 0.023* |
 No | 162 (90.0) | 99/162 (61.1) | 0.55 [0.28–1.06] | |
Side effects with actual ART prescription | Â | |||
 Yes | 92 (51.1) | 62/92 (67.4) |  | 0.012* |
 No | 88 (48.9) | 43/88 (48.9) | 1.38 [1.07–1.78] | |
Action taken with side effects | Â | |||
 Ask for medical advice | 57 (62.0) | 38/57 (66.7) |  | 0.031* |
 Wait it to stop | 28 (30.4) | 22/28 (78.6) | 1.18 [0.90–1.54] | |
 Keep taking my ART | 4 (4.3) | 2/4 (50) | 0.75 [0.28–2.03] | |
 Did not answer | 3 (3.3) | 0/3 (0) | – | |
ART abandoned at anytime | ||||
 Yes | 83 (46.1) | 72/83 (86.7) |  | 0.001* |
 No | 97 (53.9) | 33/97 (34) | 2.55 [1.91–3.41] | |
Length of ART abandon | ||||
 > 30 days | 15 (18.1) | 9/15 (60) |  | 0.001* |
 10–30 days | 16 (19.3) | 14/16 (87.5) | 1.46 [0.93–2.29] | |
 1–9 days | 52 (62.7) | 49/52 (94.2) | 1.57 [1.03–2.39] | |
Reason for abandonment | ||||
 Forgetfulness or neglect when attending a commitment, meeting or work | 35 (40.7) | 35/35 (100) |  | 0.033* |
 Bureaucracy to get access to ART | 17 (19.8) | 13/17 (76.5) | 0.76 [0.59–1.00] | |
 Lack of privacy or feeling better | 11 (12.8) | 9/11 (81.8) | 0.82 [0.62–1.08] | |
 Fear of side effects | 8 (9.3) | 6/8 (75) | 0.75 [0.50–1.12] | |
 Others | 15 (17.4) | 11/15 (73.3) | 0.73 [0.54–1.00] |